RESULTS
Five patients with segmental NS > 20 cm were included; 2 men and 3 women with a mean age of 45.8 years at first follow-up (Table SI  1 and Fig. 1 ). The back was the most common site of the NS. Two patients had NS smaller than 40 cm in diameter and 3 patients had NS larger than 40 cm. Two patients had congenital NS and 3 patients developed NS during childhood. Follow-up ranged from 10 to 120 months. Four invasive melanomas and one melanoma in situ appeared in 3 of our 5 patients. Three melanomas developed within the NS; patient 2 developed a melanoma within the NS on the leg, patient 3 developed 2 melanomas within the NS on the back and arm. In patient 3 a melanoma developed outside of the NS on the back. The melanoma in situ developed within the NS of patient 1 on the back. Melanomas were excised following the standard protocols, and histopathological investigation confirmed the diagnosis. In our cases, histopathology showed 2 superficial spreading melanomas; the subtypes of the other melanomas were unknown.
A review of the literature showed 11 other publications with segmental NS and melanoma (5, 11-13, 19, 27, 28, 33-36) . However, it sometimes remained unclear whether a large or segmental NS was described.
DISCUSSION
We describe here 5 patients with NS > 20 cm with a segmental distribution. Three of 5 patients developed The specific risk of melanoma in large segmental NS has not been studied in the literature so far. A former analysis of 4 case reports concluded that the risk of developing a malignancy in a NS seems to increase when its size is ≥ 4 cm (9). In our patients, melanoma developed in 2 out of 3 patients with segmental NS > 40 cm. Another risk factor seems to be time of appearance of the NS. Two studies reported that in the majority of melanoma cases the NS were congenital (27, 28). It has been suggested that acquired NS have a different behaviour in terms of malignancy compared with congenital NS (13) . Melanomas in our case series developed in both congenital and acquired NS. Also, the risk of developing a melanoma might be higher when the type of NS is macular rather than papular (9, 40) . Lastly, the majority of published case reports of melanomas in NS are of the type SSM (5, 9, 28), followed by nodular melanoma. In our study, 2 superficial spreading melanomas (SSM), one melanoma of unknown type and one melanoma in situ developed within the segmental NS in 3 patients, all with a Breslow thickness < 1 mm.
Melanoma in Segmental Naevus
The risk for melanoma arising in giant congenital naevi (according to the definition as > 20 cm in adulthood) is reported to be 5-15% (41). Although further data from the literature are missing, the risk of melanoma arising in giant congenital naevi seems to be lower than in large segmental NS. The fact that the Leiden University Medical Centre is a tertiary referral centre might explain the high number of melanoma (60%) in our case series, as a selection bias may have occurred; however, we think that most cases with a large segmental NS will be referred to our institution since our centre is the reference centre for the Netherlands.
Based on the case series reported here and the current literature, it appears that the risk of developing a melanoma in patients with (segmental) NS increases with lesions > 40 cm, harbouring a significant risk for the development of melanoma. It is unknown if the segmental distribution of NS contributes to the risk of melanoma. Since there are only reports on small case series, conclusions about other risk factors are speculative. Guidelines for the management of NS are lacking. We recommend following up patients with large segmental NS at least once per year with the aid of detailed photographs. Patients should be instructed how to perform self-examination. Suspicious lesions should be biopsied and sent for histopathological evaluation. An international database of large NS and multicentre studies on prevalence and risk factors of melanoma in (segmental) NS are needed to further characterize these patients and develop proper guidelines.
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